Clinical Trial Update: A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

View source ↗

Summary

A real-world observational study in adults with severe eosinophilic asthma in Italy is evaluating outcomes for patients treated with benralizumab; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• Benralizumab (Fasenra) (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Eosinophilic Asthma | Status: RECRUITING